Editorial: understanding differences in patient response to ondansetron in irritable bowel syndrome with diarrhoea-are we any closer? Authors' reply

Aliment Pharmacol Ther. 2019 Oct;50(7):826-827. doi: 10.1111/apt.15465.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Diarrhea
  • Humans
  • Irritable Bowel Syndrome*
  • Ondansetron
  • Receptors, Serotonin, 5-HT3
  • Serotonin

Substances

  • Receptors, Serotonin, 5-HT3
  • Serotonin
  • Ondansetron